• Home
  • Geert Cauwenbergh
Geert Cauwenbergh

Geert Cauwenbergh

35.98
 · 
Doctor of Medical Sciences

About

111
Publications
10,135
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
3,014
Citations

Publications

Publications (111)
Abstract 3478: Management of chemotherapy induced alopecia using a topical botanical lotion via a proposed triple-action on apoptosis, inflammation and collagen
Article
  • Jul 2016
1563 A topical botanical lotion improves recovery from chemotherapy alopecia and persistent hair issues in cancer survivors through local modulation of apoptosis and inflammation
Article
  • Sep 2015
Abstract 3436: A topical botanical product improves recovery from chemotherapy alopecia and persistent hair issues in cancer survivors
Article
  • Aug 2015
Abstract P1-09-32: A novel candidate for chemotherapy induced alopecia (CIA) through local modulation of apoptosis and inflammation
Article
  • May 2015
Drug pricing and reimbursement in Europe: Strategy and tactics
Article
  • Dec 2009
Drug pricing and reimbursement in Europe: Strategy and tactics
Article
  • Dec 2009
The Treatment of Aspergillosis and Aspergilloma with Itraconazole, Clinical Results of an Open International Study (1982 - 1987)/Die Behandlung der Aspergillose und des Aspergilloms mit Itraconazol, Klinische Ergebnisse einer offenen internationalen Studi
Article
  • Sep 2009
Experience with Itraconazole in Deep Mycoses in Northern Italy. Erfahrungen mit Itraconazol bei tieflokalisierten Mykosen in Norditalien
Article
  • May 2009
Novelties in the multifaceted miconazole effects on skin disorders
Article
  • Aug 2008
The efficacy of oral treatment with pramiconazole in tinea pedis and tinea cruris/corporis: Two exploratory phase IIa trials
Article
  • May 2008
Oral vapitadine, a new non-sedating antihistamine, relieves itch associated with atopic dermatitis
Conference Paper
  • Feb 2008
Efficacy of a single oral dose of 200 mg pramiconazole in vulvovaginal yeast infections: An exploratory phase IIa trial
Article
Full-text available
  • Jan 2008
Established and Emerging Oral Antifungals in Dermatology
Chapter
  • Dec 2007
ITRACONAZOLE IN THE TREAMENT OF CHROMOBLASTOMYCOSIS DUE TO FONSECAEA PEDROSOI
Article
  • May 2007
A Pilot Study on Seborrheic Dermatitis Using Pramiconazole as a Potent Oral Anti-Malassezia Agent
Article
  • Feb 2007
The pharmacodynamic and pharmacokinetic profile, safety and tolerability of the new H1 anti-histamine, vapitadine (R129160; hivenyl (TM)), after single and multiple oral doses in healthy volunteers.
Article
  • Jan 2007
Tensile properties and contours of aging facial skin. A controlled double-blind comparative study of the effects of retinol, melibiose-lactose and their association
Article
  • Oct 2006
Short oral therapy in difficult‐to‐treat tinea infections
Article
  • Jul 2006
Effect of a single overnight topical application of miconazole nitrate paste on acne papules
Article
  • Apr 2006
Healing effect of ketanserin on chronic leg ulcers in patients with diabetes
Article
  • Apr 2006
Dynamics of Skin Barrier Repair following Topical Applications of Miconazole Nitrate
Article
  • Feb 2006
Activity of the Triazole Antifungal R126638 as Assessed by Corneofungimetry
Article
  • Feb 2006
New insights in the effects of topical ketoconazole
Article
  • Jan 2006
Fungal Infections of the Skin: Infection Process and Antimycotic Therapy
Article
  • Jan 2006
Corneofungimetry Bioassay on Malassezia spp. under Ketoconazole and Desonide Influences
Article
  • Mar 2005
Coping with mild inflammatory catamenial acne. A clinical and bioinstrumental split-face assessment
Article
  • Nov 2004
The role of the pharmaceutical industry in drug development in dermatology
Article
  • Sep 2002
Split face study of cutaneous tensile effect of a 2-diemthylaminoethanol (deanol) gel
Article
  • Sep 2002
Antiparasitic Agents, Antimycotics
Chapter
  • Dec 2000
A Randomized, Placebo-Controlled Trial of Topical Retinol in the Treatment of Cellulite
Article
  • Nov 2000
Dermatotherapeutic Agents
Chapter
  • Jun 2000
Unraveling the Patterns of Subclinical Pheomelanin-Enriched Facial Hyperpigmentation: Effect of Depigmenting Agents
Article
  • Feb 2000
Correlation between Malassezia spp. load and dandruff severity
Article
  • Jun 1998
Ketoconazole Shampoo: Effect of Long-Term Use in Androgenic Alopecia
Article
Full-text available
  • Feb 1998
New Insight into the Topical Management of Excessive Sebum Flow at the Skin Surface
Article
  • Feb 1998
The Effects of Tryspin on Apoptosis, Utriculi Size, and Skin Elasticity in the Rhino Mouse
Article
  • Oct 1997
Trypsin‐induced follicular papilla apoptosis results in delayed hair growth and pigmentation
Article
Full-text available
  • Apr 1997
Age-Related Changes in Facial Skin Contours and Rheology
Article
  • Mar 1997
Modulation of sebum excretion from the follicular reservoir by a dichlorophenyl-imidazoldioxolan
Article
  • Nov 1996
Effect of ketoconazole-medicated shampoos on squamometry and Malassezia ovalis load in Pityriasis capitis
Article
  • Oct 1996
Effect of Food on the Pharmacokinetics of a New Hydroxypropyl‐β‐Cyclodextrin Formulation of Itraconazole
Article
  • May 1996
Fungal cultures on cyanoacrylate skin surface strippings as a dose-finding method for topical antifungals. A placebo-controlled study with 0·25% and 0·50% itraconazole cream
Article
  • Mar 1995
[Pharmacokinetics of itraconazole]
Article
  • Feb 1994
Characterization of HIV-1 Strains Isolated from Patients Treated with TIBO R82913
Article
  • Feb 1994
Anti-inflammatory activity of topical ketoconazole. A double-blind comparison with 1% hydrocortisone
Article
  • Jan 1994
Antifungal Therapy
Chapter
  • Jan 1994
Cryptococcal meningitis: The place of itraconazole
Article
  • Jul 1993
Itraconazole Plasma and Vaginal Mucosal Levels in Patients with Chronic Vaginal Candidosis Treated with Itraconazole 200mg Once Daily for 3 Consecutive Days
Article
  • Jul 1993
Antifungal prophylaxis and empiric therapy in neutropenic patients
Article
  • Feb 1993
Pharmacokinetics of R 82913 in AIDS patients: A phase I dose-finding study of oral administration compared with intravenous infusion
Article
Full-text available
  • Jan 1993
Potent and highly selective HIV-1 inhibition by a new series of α-anilinophenylacetamide (α-APA) derivatives targeted at HIV-1 reverse transcriptase
Article
Full-text available
  • Jan 1993
Treatment of Phaeohyphomycosis and Pityriasis Versicolor
Chapter
  • Jan 1993
Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi
Article
  • Dec 1992
Treatment of Hyperkeratotic Skin Diseases With R 68151, a Topical 5-Lipoxygenase Inhibitor: Four Case Reports
Article
  • Aug 1992
Posttreatment itraconazole levels in the nail: New implications for treatment in onychomycosis
Article
Full-text available
  • Jun 1992
Recent Progress in Antifungal Chemotherapy
Article
  • Feb 1992
Itraconazole Compared with Griseofulvin in the Treatment of Tinea corporis/cruris and Tinea pedis/manus: An Interpretation of the Clinical Results of all Completed Double-Blind Studies with Respect to the Pharmacokinetic Profile
Article
  • Feb 1992
Skin Kinetics of Azole Antifungal Drugs
Article
  • Feb 1992
Oral candidosis: Treatment with absorbable and non-absorbable antifungal agents in children
Article
  • Jan 1992
Mycoses in AIDS Patients
Article
  • Jan 1992
Phase II trial: An evaluation of oral saperconazole in acute vaginal candidosis: a comparison of three dosage schedules
Article
  • Nov 1991
Itraconazole penetrates the nail via the nail matrix and the nail bed - An investigation in onychomycosis
Article
Full-text available
  • Oct 1991
The antiinflammatory effects of ketoconazole: A comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus aureus on the skin of guinea-pigs
Article
  • Sep 1991
Pharmacokinetics of R 82913 in patients with AIDS or AIDS-related complex
Article
  • Aug 1991
Safety aspects of itraconazole therapy in vaginal candidosis, dermatomycosis, and onychomycosis. A review
Article
  • Jan 1991
Management of fungal skin infections with 15 days itraconazole treatment: a worldwide review
Article
  • Oct 1990
Pharmacokinetics of oral antifungals and their implications
Article
  • Oct 1990
A double-blind vehicle-controlled study of R 68 151 in psoriasis: A topical 5-lipoxygenase inhibitor
Article
  • Jun 1990
Vaginal candidiasis: Evolving trends in the incidence and treatment of non-Candida albicans infections
Article
  • Jan 1990
Pharmacokinetics of Antifungals
Chapter
  • Jan 1990
Mycoses in AIDS Patients
Book
  • Jan 1990
The Role of Cytochrome P‐450 in Dermatology
Article
  • Nov 1989
Cytochrome P-450 and the Skin
Article
  • Oct 1989
Terconazole: Pharmacology of a new antimycotic agent
Article
  • Sep 1989
Use of topical ketanserin in the treatment of skin ulcers: A double-blind study
Article
  • Aug 1989
FLUCONAZOLE VERSUS KETOCONAZOLE IN OROPHARYNGEAL CANDIDIASIS IN AIDS
Article
  • May 1989
Safety Aspects of Ketoconazole, the Most Commonly Used Systemic Antifungal
Article
  • Feb 1989
Itraconazole Versus Ketoconazole for the Prophylaxis of Fungal Infection in Neutropenic Children: Results of Two Consecutive Nonrandomized Studies
Article
  • Feb 1989
The Clinical Pharmacokinetics of Itraconazole: An Overview
Article
  • Feb 1989
The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987)
Article
  • Oct 1988
Pharmacokinetic profile of orally administered Itraconazole in human skin
Article
  • Mar 1988
Role of Animal and Human Pharmacology in Antifungal Drug Design
Article
  • Feb 1988
Traitement à l'itraconazole de la cryptococcose cérébrale et pulmonaire
Article
  • Jan 1988
Prophylaxis of Aspergillosis in Immunocompromised Patients
Chapter
  • Jan 1988
Dermatophytosis, Parasitosis, Mycobacteriosis Therapy/Experimental Results
Chapter
  • Jan 1988
Aspergillus and Aspergillosis
Book
  • Jan 1988
Pityriasis versicolor and Pityrosporum ovale. Morphogenetic and ultrastructural considerations
Article
  • Dec 1987
Pityriasis Versicolor and Pityrosporum ovale
Article
  • Nov 1987
Experience with itraconazole in deep mycoses in Northern Italy
Article
  • Jun 1987
Experience with itraconazole in treatment of fungal infections
Article
  • Feb 1987
Itraconazole in the Treatment of Human Mycoses: Review of Three Years of Clinical Experience
Article
  • Jan 1987
Itraconazole: Pharmacologic Studies in Animals and Humans
Article
  • Jan 1987
Ketoconazole vs. Itraconazole for Antifungal Prophylaxis in Patients with Severe Granulocytopenia: Preliminary Results of Two Nonrandomized Studies
Article
  • Jan 1987
Itraconazole: The first orally active antifungal for single-day treatment of vaginal candidosis
Article
  • Jan 1987
The clinical use of itraconazole in superficial and deep mycoses
Article
  • Jan 1987
Kétoconazolevs itraconazole for antifungal prophylaxis in patients with severe granulocytopenia
Article
  • Jan 1987
Treatment of Dandruff With a 2% Ketoconazole Scalp Gel
Article
  • Nov 1986
Itraconazole pharmacokinetics in the female genital tract: Plasma and tissue levels in patients undergoing hysterectomy after a single dose of 200 mg itraconazole
Article
  • Nov 1986
The pharmacology of agents used in the treatment of pulmonary mycoses
Article
  • Oct 1986
Itraconazole therapy in pityriasis versicolor
Article
  • Sep 1986

Network

Cited
View All
Cited By
View All
Followers
View All
Following
View All

Projects

Project (1)
antimycotics
Archived project